Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs Lockheed Martin Corporation (LMT) Price & Performance

Quest Diagnostics IncTrade
Lockheed Martin CorporationTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs Lockheed Martin Corporation — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Lockheed Martin Corporation trades at $596.99 (market cap $137.96B). The key difference: Lockheed Martin Corporation is far larger — about 5.3× Quest Diagnostics Inc's market cap, and Lockheed Martin Corporation pays the higher dividend (2.31%). Which is the better fit depends on your goals.

DGXLMT
Market Cap
$26.21B$137.96B
Sector
HealthIndustrials
52-Week High
$238.50$676.70
52-Week Low
$173.49$431.56
Enterprise Value
$31.97B$154.71B
Dividend Yield
1.45%2.31%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX

About Lockheed Martin Corporation

Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.

Read more on LMT